Lyra Therapeutics Inc. (LYRA)
NASDAQ: LYRA
· Real-Time Price · USD
7.06
-0.04 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
6.87
-2.69%
After-hours: Aug 15, 2025, 06:51 PM EDT
Lyra Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 770K | 1.19M | 1.53M | 1.47M | 1.82M | 1.68M | 1.56M | 1.42M | 1.24M | 1.19M | 6.14M | 6.4M | 6.06M | 5.65M | 285K | 14K | n/a | n/a |
Cost of Revenue | 239K | 184K | 320K | 405K | 12.73M | 23.39M | 23.25M | 23.39M | 11.02M | 522K | 802K | 594K | 6.97M | 6.97M | 6.76M | 10.49M | 7.83M | 7.53M |
Gross Profit | 570K | -12.08M | -11.87M | -12.01M | -24.03M | -21.71M | -21.69M | -21.97M | -9.78M | 665K | 5.34M | 5.81M | -912K | -1.32M | -6.48M | -10.48M | -7.83M | -7.53M |
Operating Income | -41.12M | -81.67M | -96.35M | -101.42M | -105.8M | -73.33M | -67.12M | -65.8M | -63.8M | -61.81M | -51.52M | -50.01M | -46.26M | -42.81M | -43.62M | -37.03M | -32.31M | -25.79M |
Interest Income | 1.72M | 2.16M | 2.95M | 3.85M | 4.47M | 4.51M | 4.5M | 4.09M | 2.96M | 2.1M | 1.04M | 129K | 95K | 87K | 102K | 113K | 116K | 95K |
Pretax Income | -38.82M | -79.5M | -93.4M | -97.56M | -101.33M | -68.82M | -62.62M | -61.7M | -60.84M | -59.71M | -50.48M | -49.88M | -46.17M | -42.72M | -43.51M | -36.92M | -32.2M | -25.7M |
Net Income | -38.84M | -79.53M | -93.44M | -97.61M | -101.39M | -68.88M | -62.68M | -61.76M | -60.87M | -59.67M | -50.41M | -49.52M | -45.81M | -42.43M | -43.23M | -36.92M | -32.2M | -25.7M |
Selling & General & Admin | 14.11M | 15.95M | 18.5M | 19.25M | 20.32M | 19.75M | 19.06M | 19.1M | 19.23M | 18.8M | 17.56M | 16.72M | 15.61M | 15.03M | 14.21M | 13.95M | 12.58M | 11.46M |
Research & Development | 22.25M | 30.4M | 43.63M | 49.45M | 55.91M | 53.45M | 47.94M | 45.21M | 42.89M | 42.89M | 38.8M | 39.69M | 36.72M | 33.43M | 29.69M | 23.09M | 19.73M | 14.33M |
Other Expenses | 5.33M | 23.24M | 22.35M | 20.71M | 17.91M | 1.59M | 1.59M | 2.91M | 2.91M | 1.32M | 1.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 41.69M | 69.59M | 84.48M | 89.4M | 94.14M | 73.2M | 67M | 64.31M | 62.13M | 61.68M | 56.35M | 56.41M | 52.32M | 48.46M | 43.9M | 37.04M | 32.31M | 25.79M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.89M | 82.85M | 97.88M | 102.89M | 107.62M | 73.42M | 67.09M | 64.31M | 62.13M | 61.68M | 56.35M | 56.41M | 52.32M | 48.46M | 43.9M | 37.04M | 32.31M | 25.79M |
Income Tax Expense | 19K | 29K | 39K | 50K | 27K | 27K | 27K | 23K | 39K | -41K | -69K | -360K | -386K | -344K | -359K | -113K | -116K | -95K |
Shares Outstanding (Basic) | 1.35M | 65.76M | 65.11M | 65.46M | 65.46M | 64.01M | 61.24M | 56.95M | 43.68M | 36.83M | 31.71M | 36.83M | 33.95M | 13.01M | 12.97M | 13M | 12.99M | 12.95M |
Shares Outstanding (Diluted) | 1.35M | 65.76M | 65.11M | 65.46M | 65.46M | 64.01M | 61.53M | 56.95M | 43.68M | 36.83M | 31.83M | 36.83M | 33.95M | 13.01M | 13M | 13M | 12.99M | 12.95M |
EPS (Basic) | -5.99 | -1.21 | -1.43 | -1.51 | -1.6 | -1.23 | -1.32 | -1.52 | -1.65 | -1.71 | -2.19 | -2.79 | -3.24 | -3.67 | -3.35 | -2.84 | -2.48 | -2.19 |
EPS (Diluted) | -5.99 | -1.21 | -1.43 | -1.51 | -1.6 | -1.23 | -1.32 | -1.52 | -1.65 | -1.71 | -2.19 | -2.79 | -3.24 | -3.67 | -3.35 | -2.84 | -2.48 | -2.19 |
EBITDA | -34.86M | -45.29M | -60.26M | -67.04M | -74.27M | -71.52M | -65.16M | -62.38M | -60.1M | -59.31M | -53.92M | -53.67M | -49.85M | -46.5M | -42.61M | -36.27M | -31.86M | -25.64M |
EBIT | -35.38M | -45.75M | -60.73M | -67.44M | -74.63M | -71.74M | -65.53M | -62.89M | -60.89M | -60.38M | -54.99M | -54.79M | -51.04M | -47.71M | -43.62M | -37.03M | -32.31M | -25.79M |
Depreciation & Amortization | 518K | 463K | 471K | 405K | 298K | 130K | 278K | 415K | 762K | 1.08M | 1.08M | 1.14M | 1.26M | 1.26M | 1.05M | 811K | 444K | 157K |